Tue12062022

Last updateMon, 05 Dec 2022 4pm

Back You are here: Inicio Biology & biomedicine

New drug composition for uveal melanoma developed

CSIC has developed a pharmaceutical composition to treat uveal melanoma, a cancer that forms from melanin-producing cells in the eye. Although it has a low incidence, it is the most common eye cancer in adults. There are a few standard treatments for the primary tumour, but not for metastatic uveal melanoma of the eye.

Read more ...

Scientists create proteins that do not exist in nature and that mimic the immunoglobulins of antibodies

Computational design has made it possible to create proteins that mimic the folded immunoglobulin structure of natural antibodies. They can be used as a basis for the development of tailor-made and more economical antibody-like drugs. These results open the door to the design of antibody-like proteins with tailored structures and better biophysical properties than current ones.

Read more ...

Improving the efficacy of cancer treatments with nanomaterials

A project at the ICMAB-CSIC in Barcelona is using nanomaterials to improve cancer treatment. The team, led by Gerard Tobias, has won funding from the European Research Council (ERC) to explore the commercial and societal potential of the research results.

Read more ...

Scientists develop the first portable magnetic resonance device

A team from the Institute of Instrumentation for Molecular Imaging (i3M), a joint centre of the CSIC and the Polytechnic University of Valencia, has developed the first portable magnetic resonance imaging. It is a low-cost device that can be used in situations where this diagnostic technique is usually ruled out for technical or economical reasons.

Read more ...

Pregnant women with low weight can transfer more organochlorine pollutants into breastmilk

Some pollutants are known to accumulate in the body's fatty tissue. How does this affect pregnant women? there a link between weight gain and the transfer of pollutants to the newborn? A new study provides new data that can help the administration and health managers in their decision making.

Read more ...